Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Pharmacy Residency Programs

  • pharmacy residents

  • Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life-changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment, where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health, particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment; we educate tomorrow's physician/researchers; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

    The Pharmacy department leads programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

  • Contact Us

    For more information, please contact:

    Oncology PGY-2

    Hillary A. Prescott, PharmD, BCOP
    Residency Program Director / Manager of Pharmacy Clinical Services
    hillary_prescott@dfci.harvard.edu

    Pain Management/Palliative Care PGY-2

    Bridget Fowler Scullion, PharmD, BCOP
    Residency Program Director / Director, Clinical Pharmacy Services
    bridget_scullion@dfci.harvard.edu

    Medication Safety PGY-2

    Mona Hammam, PharmD, MS, BCPS, FISMP
    Residency Program Director/Medication Safety Specialist
    mona_hammam@dfci.harvard.edu

  • At Dana-Farber, we work every day to create an innovative, caring, inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we're equally committed to diversifying our faculty and staff. Cancer knows no boundaries, and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

  • About the Pharmacy Residency Programs

    Dana-Farber Cancer Institute is proud to offer three ASHP-accredited Post-Graduate Year 2 (PGY-2) Pharmacy Residency Programs:

    • Oncology Pharmacy Residency (Onc) – 2 positions
    • Pain Management/Palliative Care Pharmacy Residency (PMPC) – 1 position
    • Medication-Use Safety and Policy (MUS) – 1 position

    These positions are designed to provide the resident with opportunities to develop clinical competence in pharmacy practice. Residents are exposed to a multitude of experiences related to patient care, involving both inpatient care and ambulatory-related experiences.

    Pharmacy resident benefits

    Pharmacy residents will receive competitive benefits for the PGY-2 residency year: 

      • Holidays: New Year’s Day, Martin Luther King Jr. Birthday Observance, President’s Day, Memorial Day, Juneteenth Observance, Independence Day, Labor Day, Indigenous Peoples' Day, Thanksgiving Day, and Christmas Day are all observed holidays.
      • Vacation Days: Residents are entitled to 10 days of vacation. Vacation days are to be approved by the residency director and sufficient notice given.
      • Professional Meetings/Professional Days: Residents attend two national, and up to two local professional meetings, including ASHP Mid-Year Meeting. Conference fee and travel compensation are provided. Residents are entitled to 10 professional days, which cover travel for professional meetings.
      • Sick Days: Residents will earn one sick day per month. Sick days may be used in accordance with Dana-Farber policies.
      • Salary and Benefits: The annual resident salary is $60,000. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes.
    • Oncology Pharmacy Residency (Onc)

      Overview

      The Dana-Farber Cancer Institute (DFCI) PGY-2 Oncology Pharmacy Residency is a 12-month postgraduate educational and training experience designed to develop advanced knowledge, skills, and leadership in the delivery of pharmaceutical services to patients with cancer. Residents who successfully complete a PGY-2 oncology pharmacy residency at Dana-Farber will be prepared to become proficient and board-certified clinical oncology pharmacy practitioners, educators, and leaders.

      Residents in the Oncology Pharmacy Residency will gain experience in a variety of areas of clinical oncology practice, including inpatient and outpatient adult solid tumor and hematologic malignancies, palliative care, pediatric oncology, ambulatory infusion pharmacy, and investigational drug services. In addition to providing direct patient care, residents are involved in various educational, safety, administrative, and research projects.

      Purpose

      PGY-2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings.

      Outcomes

      The DFCI PGY-2 Oncology Pharmacy Residency is constructed to develop the resident’s knowledge and experience in various areas of oncology pharmaceutical care, therapeutics, academia, and other areas of oncology pharmacy to acquire the skills necessary for practicing at the top of their license. Residents completing the DFCI PGY-2 Oncology Pharmacy Residency will have developed their clinical, leadership and research skills, time management, interpersonal communication and teaching approach. Upon completion of the residency, the resident will be prepared and well qualified to enter into various fields of clinical oncology pharmacy practice. The resident is expected to provide accurate, professional, detailed and quality driven services for each task they complete. The resident will be held accountable for participation in their own professional development including professional presentations and teaching experiences in addition to developing their long-term career goals.

      Through these educational experiences, residents will:

      • Provide evidence-based and patient-centered care to oncology patients within interdisciplinary teams.
      • Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and formal presentation.
      • Refine communication and time management skills.
      • Conduct a year-long, publishable oncology-related research or quality improvement project.
      • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

      Oncology Pharmacy Learning Experiences

      Core Clinical Learning Experiences

      • Orientation (2 weeks)
      • Medical oncology (inpatient, 4 weeks)
      • Hematologic oncology (inpatient, 4 weeks)
      • Ambulatory lymphoma (4 weeks)
      • Ambulatory multiple myeloma (4 weeks)
      • Ambulatory genitourinary (4 weeks)
      • Ambulatory solid tumors (4 weeks)
      • Palliative care (inpatient/ambulatory, 4 weeks)
      • Stem cell transplant (inpatient, 4 weeks)
      • Investigational drug service (ambulatory, 2 weeks)

      Longitudinal Learning Experiences

      • Medication safety (3 months)
      • Pharmacy administration (10 months)
      • Oral antineoplastic teach (10 months)
      • Weekly oncology topic discussions (12 months)
      • Academia (10 months)
      • Research (12 months)
      • Ambulatory oncology infusion pharmacy (12 months)
      • Pediatric oncology (ambulatory, 8 weeks)

      Elective Learning Experiences

      Four weeks of the year are dedicated to an elective based on resident interest. They may choose to repeat a core rotation (listed below) or pursue a different area of interest.

      • Medical Oncology II
      • Hematologic Oncology II
      • Inpatient CAR-T Cell Therapy
      • Clinical Pharmacy Informatics
      • Ambulatory BMT
      • Ambulatory Breast

      Residency Learning Experiences/Educational Activities

      Research Project

      Research projects will be determined according to the resident's interest and departmental needs. The resident is required to complete one project and present a poster at the HOPA (Hematology/Oncology Pharmacy Association) annual conference. Research results will be shared with pharmacists in the Boston area at a roundtable research event sponsored by Dana-Farber. The resident will also prepare a finished manuscript suitable for publication by the end of the residency year.

      Examples of past resident research projects include:

      • Decreasing Costs and Clinic Wait Time While Maintaining Safety for Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) for Multiple Myeloma (accepted Oral Presentation at ASH 2021)
      • Mapping myeloma using clinical pathways: a roadmap of daratumumab use (accepted ASH poster presentation, 2021)
      • Evaluation of infusion reactions in patients receiving daratumumab post-implementation of an augmented pre- and peri-medication regimen (accepted ASH poster presentation, 2018)
      • Evaluation of thromboembolic events in patients receiving direct oral anticoagulation therapy (accepted ASH poster presentation, Dec 2017)

      Medication-Use Evaluations (MUEs)

      Residents complete a MUE during the first half of the year to present by poster at the ASHP Midyear Meeting. Residents are presented with MUE topics at the start of the residency year and may collaborate on one MUE or choose separate MUEs.

      Continuing Education (CE) Programs

      Dana-Farber’s Department of Pharmacy is approved by the Accreditation Council for Pharmacy Education (ACPE) to offer continuing education programs for pharmacists and technicians. Residents are required to provide one ACPE-accredited CE presentation during the residency year (Fall, Winter or Spring).

      Didactic Lectures

      Dana-Farber’s PGY-2 Oncology Pharmacy Residency gives residents opportunities to lecture students at MCPHS University – Boston. Residents are expected to present one lecture (Winter/Spring) for the oncology elective at MCPHS University. Residents may co-present an assigned topic or choose a topic of their choice.

      Precepting Experience

      Residents are provided with opportunities to co-precept students affiliated with Northeastern School of Pharmacy and MCPHS University during their inpatient Medical Oncology and Palliative Care learning experiences.

    • Pain Management/Palliative Care Pharmacy Residency (PMPC)

      The Dana-Farber Cancer Institute PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings.

      The PGY-2 Pain Management and Palliative Care Pharmacy resident will gain experience in the following areas of practice: inpatient and outpatient palliative care, hospice, inpatient and outpatient pain management, and pain management in the primary care setting. Primary rotation sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University.

      Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program, which provides a nationally rare opportunity for a pharmacy resident to join a fellowship with physician and nurse practitioner fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program, which offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team. There are also opportunities to work with our pediatric palliative care fellows.

      Throughout these experiences a resident completing the program will be able to:

      • Demonstrate development as a role model for clinical pharmacists in the pain management and palliative care setting.
      • Develop various teaching styles and approaches for application in a variety of settings, including experiential education, small group teaching, and group lecture.
      • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
      • Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
      • Refine communication and time management skills.
      • Develop, implement and analyze data of a yearlong, publishable research or quality project.
      • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

      Pain Management/Palliative Care Learning Experiences

      Core Clinical Learning Experiences

      • Orientation (2 weeks)
      • Intensive Palliative Care Unit (6 weeks)
      • Hospice (6 weeks: 4 weeks in Fall followed by 2 weeks in Spring)
      • Inpatient Palliative Care Consult Team (6 weeks)
      • Administration (2 weeks followed by a longitudinal project)
      • Ambulatory pain management (12 weeks)
      • Academia (12 weeks concurrent with Ambulatory Pain Management)
      • Post-Operative Pain Management Service (2 weeks)

      Longitudinal Learning Experiences

      • Outpatient Palliative Care Clinic (16 weeks)
      • Harvard Interprofessional Palliative Care Fellowship (12 months)
      • Residency Project
      • Outpatient Pharmacy Department Staffing (6 months)
      • Medication-Use Management (6 months)
      • Substance Use Disorders (4 months)

      Elective Learning Experience Opportunities

      • Palliative Care Clinic II
      • Hospice II
      • Palliative Care Consult II
      • Intensive Palliative Care Unit II
      • Oncology
    • Medication-Use Safety & Policy

      By actively participating in medication error, pharmacy intervention, and adverse drug event reporting processes, the PGY-2 Medication-Use Safety Pharmacy Resident will gain experience in medication safety assessment, as well as quality and process improvement. The resident will participate in several medication safety-related activities, such as root cause analyses, system assessments, and quality/process improvement projects.

      The resident will also lead the interdisciplinary pharmacy intervention subcommittee; serve as a member of the ambulatory event committee and pharmacy and therapeutics committee; and will partake in various clinical informatics workgroups. Other activities may include conducting pharmacy safety rounds, policy and guideline development, and workflow development and implementation – all while promoting a culture of safety within the department and across the Institute. The resident will foster these skills in the outpatient, inpatient, adult, and pediatric settings.

      The resident will work closely with other interdisciplinary departments, including the Center of Patient Safety, Risk Management, Quality/Process Improvement, Clinical Informatics, and others.

      The fundamental goal of the residency is to provide training so that pharmacists develop excellent knowledge in the principles of medication-use safety; communication and leadership; and strategies to collect, analyze, and implement changes to clinical and operational processes that promote safe medication-use practices.

      Throughout these experiences, a resident completing the program will be able to:

      • Understand and utilize methods to promote safety
      • Provide comprehensive evaluation of medication events and participate in the development and implementation of mitigation strategies
      • Review, analyze, and categorize near-miss medication reports; identify patterns necessitating further evaluation; and lead efforts to develop improvement strategies
      • Utilize data provided by technology to analyze medication-use practice; participate in the implementation of technologies that promote safety medication-use practices
      • Participate in the analysis and mitigation of medication-use system issues due to changes in USP800, technology, communication issues, or other factors as they arise
      • Analyze and understand complex systems and human factors to implement solutions that minimize medication safety gaps
      • Participate and lead committees and efforts that promote medication safety
      • Complete a longitudinal research project that improves the quality and safety of the medication-use process

      Core Clinical Learning Experiences

      • Ambulatory Oncology
      • Hematology Malignancies
      • Investigational Drug Service

      Longitudinal Learning Experiences

      • Medication-Use Safety & Safety Report Analysis
      • Quality/Process Improvement
      • Clinical Pharmacy Informatics
      • Academia
      • Oral Oncolytic Strategy and Management
      • Topic Discussions
      • Residency Research Project

      Elective Learning Experiences

      • Outpatient Pediatrics
      • Palliative Care
      • Medical Oncology
      • ISMP Rotation
      • Administration

      Other Experiences

      • Pharmacy Intervention Subcommittee
      • Ambulatory Event Subcommittee
      • Quality and Patient Safety Huddle
      • Pharmacy and Therapeutics Committee
    • Residency Program Director, Oncology

      Hillary A. Prescott, PharmD, BCOP
      Manager, Clinical Pharmacy Services
      Clinical Specialist, Lymphoma
      Education: University of Rhode Island, Providence, RI
      PGY-1: Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA
      PGY-2 Oncology: University of North Carolina Hospitals, Chapel Hill, NC
      Precepts: Ambulatory Lymphoma, Oncology Topic Discussions

      Residency Program Director, Pain Management/Palliative Care Pharmacy Residency

      Bridget Fowler Scullion, PharmD, BCOP
      Director, Clinical Pharmacy Services
      Education: St. Louis College of Pharmacy
      Palliative Care Residency: University of Maryland, School of Pharmacy, Baltimore, MD
      Precepts: Outpatient Palliative Care, Inpatient Palliative Care Consults, Harvard Interprofessional Palliative Care Fellowship, Residency Project (PMPC)

      Residency Program Director, Medication-Use Safety & Policy

      Mona Hammam, PharmD, MS, BCPS, FISMP
      Medication Safety Specialist
      Education: Long Island University, Brooklyn, NY
      Fellowship: Safe Medication Management Fellowship
      Institute of Safe Medication Practices (ISMP), Horsham, PA
      U.S. Food and Drug Administration (FDA), OSE/DMEPA (Office of Surveillance and Epidemiology, Division of Medication Error Prevention and Analysis), White Oak, MD
      Precepts: Medication Use Safety & Report Analysis (MUSP & Onc), Quality/Process Improvement (MUSP), Medication Safety Topic Discussions (MUSP)

    • Preceptors

      Oncology

      Hillary A. Prescott, PharmD, BCOP
      Manager, Clinical Pharmacy Services
      Clinical Specialist, Lymphoma
      Education: University of Rhode Island, Providence, RI
      PGY-1: Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA
      PGY-2 Oncology: University of North Carolina Hospitals, Chapel Hill, NC
      Precepts: Ambulatory Lymphoma, Oncology Topic Discussions

      Gayle C. Blouin, PharmD, BCOP
      Clinical Pharmacy Manager, Chestnut Hill and Satellite Locations; PGY2 Oncology Residency Coordinator
      Education: Northeastern University, Boston, MA (BS Pharm); MCPHS, Boston MA (PharmD)
      PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Oncology Pharmacy Administration

      Houry Leblebjian, PharmD, BCOP
      Manager, Clinical Pharmacy Practice ; Clinical Pharmacy Specialist, Myeloma
      Education: Lebanese American University, West Beirut, Lebanon
      PGY-1: UMass Memorial Medical Center, Worcester, MA
      PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Ambulatory Myeloma, Research

      Christy S. Harris, PharmD, BCPS, BCOP
      Associate Professor, MCPHS University, Clinical Pharmacy Specialist
      Education: University of Tennessee Health Sciences, Memphis, TN
      PGY-1: University of Tennessee Medical Center, Knoxville, TN
      PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
      Precepts: Academia

      Jian Ni, PharmD, MPH, BCOP
      Oncology Clinical Pharmacy Specialist, Brigham and Women’s Hospital
      Education: Massachusetts College of Pharmacy, Boston, MA (PharmD) and Columbia University Mailman School of Public Health, New York, NY (MPH)
      PGY-1: West Virginia University School of Pharmacy, Morgantown, WV
      PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Inpatient Hematopoietic Cell Transplantation

      Loriel Solodokin, PharmD, BCOP
      Assistant Professor, MCPHS School of Pharmacy-Boston; Clinical Pharmacy Specialist Hematology/Oncology, Brigham and Women’s Hospital (BWH)/Dana-Farber Cancer Institute (DFCI)
      Education: University of Illinois at Chicago College of Pharmacy
      PGY-1 Training: NYU Langone Medical Center, New York, NY
      PGY-2 Training: The Mount Sinai Hospital, Oncology, New York, NY
      Precepts: Malignant Hematology

      Andrew Skirvin, BS, PharmD, BCOP
      Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
      Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
      PGY-2 Oncology Specialty Pharmacy: Audie L. Murphy Memorial VA Hospital, San Antonio, TX
      Precepts: Medical Oncology

      Victor Phantumvanit, PharmD, BCPS, BCOP
      Clinical Pharmacy Specialist - Palliative Care
      Education: University of Maryland, School of Pharmacy, Baltimore, MD
      PGY-1: Central Washington Hospital, Wenatchee, WA
      PGY-2 Oncology & Palliative Care: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Inpatient Palliative Care

      Mona Hammam, PharmD, MS, BCPS, FISMP
      Medication Safety Specialist
      Education: Long Island University, Brooklyn, NY
      Fellowship: Safe Medication Management Fellowship
      Institute of Safe Medication Practices (ISMP), Horsham, PA
      US Food and Drug Administration (FDA), OSE/DMEPA (Office of Surveillance and Epidemiology, Division of Medication Error Prevention and Analysis), White Oak, MD
      Precepts: Medication-Use Safety

      Patrick McBride, PharmD, BCOP
      Oncology Clinical Pharmacist (Pediatrics)
      PGY-1: Children's Hospital of Wisconsin, Milwaukee, WI
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: MCPHS University, Boston, MA
      Precepts: Pediatric Oncology

      Marina Kaymakcalan, PharmD, BCOP
      Clinical Manager, Oral Antineoplastic Teach; Clinical Pharmacy Specialist, Genitourinary
      Education: Massachusetts College of Pharmacy and Health Science (MCHPS)
      Precepts: Ambulatory Genitourinary, Oral Antineoplastic Teach

      Tsz-Yi Wendy Chen, PharmD., BCPS, BCOP
      Manager of Pharmacy Infusion Services - Chestnut Hill
      Education: Purdue University
      PGY-1 Pharmacy Residency at Beth Israel Deaconess Medical Center
      Outcomes Research and Cardiology Fellowship at University of Connecticut/Hartford Hospital
      Precepts Oncology Infusion Staffing Rotation

      Jennifer Espiritu, PharmD, BCOP
      Clinical Research Pharmacist, Investigational Drug Services
      Education: Northeastern University, College of Pharmacy, Boston, MA
      Precepts: Investigational Drug Service

      Benjamin S. Kematick, PharmD, BCACP
      Clinical Pharmacy Specialist - Palliative Care
      PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: University at Buffalo, Buffalo, NY
      Precepts: Palliative Care (ambulatory component)

      Sylvia B. Bartel, RPh, MHP
      Vice President of Pharmacy Services
      Education: University of Wisconsin, Madison, WI
      PGY-1: National Institutes of Health, Clinical Center, Bethesda, MD
      Precepts: Administration


      Pain Management/Palliative Care

      Sylvia B. Bartel, RPh, MHP
      Vice President of Pharmacy Services
      Education: University of Wisconsin, Madison, WI
      PGY-1: National Institutes of Health, Clinical Center, Bethesda, MD
      Precepts: Administration

      Michele Matthews, PharmD, CPE, BCACP, FASHP
      Associate Professor of Pharmacy Practice, MCPHS University
      Advance Practice Pharmacist, Pain Management, Brigham and Women's Hospital, Boston, MA
      Education: MCPHS University, Boston, MA
      PGY-1: Robert Wood Johnson Hospital, New Brunswick, NJ
      Precepts: Ambulatory Pain Management, Academia

      Victor Phantumvanit, PharmD, BCPS, BCOP
      Clinical Pharmacy Specialist - Palliative Care
      Education: University of Maryland, School of Pharmacy, Baltimore, MD
      PGY-1: Central Washington Hospital, Wenatchee, WA
      PGY-2 Oncology & Palliative Care: Dana-Farber Cancer Institute, Boston, MA
      Precepts: Inpatient Palliative Care

      Minh Do, PharmD
      Outpatient Pharmacy Manager
      Education: MCPHS University, Boston, MA
      Precepts: Outpatient Pharmacy Department

      Inna Zinger, NP, AGPCNP-BC
      Adult Nurse Practitioner, Post-Operative Pain Service, Brigham and Women's Hospital
      Education: BSN, Northeastern University, Boston, MA; MSN, Northeastern University, Boston, MA
      Precepts: Post-Operative Pain Management Service

      Benjamin S. Kematick, PharmD, BCACP
      Clinical Pharmacy Specialist - Palliative Care
      PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
      PGY-2: Dana-Farber Cancer Institute, Boston, MA
      Education: University at Buffalo, Buffalo, NY
      Precepts: Ambulatory Palliative Care Clinic

      Alifia Waliji-Banglawala, PharmD
      Director of Pharmacy, Care Dimensions Hospice and Palliative Care, Waltham, MA
      Affiliate Assistant Clinical Professor, Northeastern University Bouve College of Pharmacy
      PGY-1: Tampa General Hospital
      Education: University of Florida, Gainesville, FL
      Precepts: Hospice


      Medication-Use Safety & Policy

      Sylvia B. Bartel, RPh, MHP
      Vice President of Pharmacy Services
      Education: University of Wisconsin, Madison, WI
      PGY-1: National Institutes of Health, Clinical Center, Bethesda, MD
      Precepts: Administration

      Gayle Blouin, PharmD, BCOP
      Clinical Pharmacy Manager
      Education: Massachusetts College of Pharmacy and Health Sciences University
      PGY-2 Training: Dana-Farber Cancer Institute/BWH, Oncology, Boston, MA
      Precepts: Research

      Angela Chen, PharmD
      Regulatory Specialist Pharmacist
      Education: Philadelphia College of Pharmacy
      PGY-1 Training: Bay Pines VA Healthcare System
      PGY-2 Training: Dana-Farber Cancer Institute, MUSP
      Precepts: Medication- Use Safety & Report Analysis

      Christy S. Harris, PharmD, BCPS, BCOP
      Associate Professor, MCPHS University, Clinical Pharmacy Specialist
      Education: University of Tennessee Health Sciences, Memphis, TN
      PGY-1: University of Tennessee Medical Center, Knoxville, TN
      PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
      Precepts: Academia

      Eno-Abasi Inyang, PharmD, BCPS, BCOP
      Clinical Pharmacy Specialist, BMT
      Education: University of Southern California, Los Angeles, CA
      PGY-1 Training: St. Joseph Medical Center, Tacoma, Washington
      PGY-2 Training: Dana-Farber Cancer Institute, Oncology
      Precepts: Ambulatory Oncology – BMT

      Marina Kaymakcalan, PharmD, BCOP
      Clinical Pharmacy Specialist
      Education: Massachusetts College of Pharmacy and Health Science (MCHPS)
      Precepts: Ambulatory Oncology - Genitourinary, Oral Anticancer Teach

      Yun Man, PharmD, BCOP
      Medication Use Quality and Policy Specialist
      Education: Massachusetts College of Pharmacy and Health Sciences University
      PGY-1 Training: VA Illiana Health Care System
      PGY-2 Training: Roswell Park Comprehensive Cancer Center, Oncology
      Precepts: Medication-Use Policy and Guideline Management

      Bridget Fowler Scullion, PharmD, BCOP
      Director, Clinical Pharmacy Services
      Education: St. Louis College of Pharmacy
      Palliative Care Residency: University of Maryland, School of Pharmacy, Baltimore, MD
      Precepts: Medication-Use Policy and Guideline Management

      Andrew Skirvin, BS, PharmD, BCOP
      Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
      Education: University of Texas Health Science Center (PharmD)
      PGY-2 Oncology Specialty Pharmacy: VA Hospital, San Antonio, TX
      Precepts: Medical Oncology Elective

      Loriel Solodokin, PharmD, BCOP
      Assistant Professor, MCPHS School of Pharmacy-Boston; Clinical Pharmacy Specialist Hematology/Oncology, Brigham and Women’s Hospital (BWH)/Dana-Farber Cancer Institute (DFCI)
      Education: University of Illinois at Chicago College of Pharmacy
      PGY-1 Training: NYU Langone Medical Center, New York, NY
      PGY-2 Training: The Mount Sinai Hospital, Oncology, New York, NY
      Precepts: Malignant Hematology

    • Current and Past Residents

      Current Residents


      Oncology

      Omar Marzouk, PharmD
      PGY-1 Training: Novant Health Presbyterian Medical Center, Charlotte, NC
      Education: University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY

      Dr. Marzouk was raised in Suffern, NY. He completed his undergraduate training and received his Doctor of Pharmacy degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. He completed his PGY-1 Pharmacy Practice Residency at Novant Health Presbyterian Medical Center in Charlotte, NC. During his time as a PGY-1 resident, he had many unique experiences in the inpatient setting, including providing pharmacy services to their first-ever CAR-T patient. At Dana-Farber, he is working on research projects characterizing ocular toxicity associated with belantamab in relapsed/refractory multiple myeloma, as well as evaluating denosumab use for hypercalcemia of malignancy. His interests include lymphoma and transplant/cellular therapies, and he hopes to pursue a career in these fields next year. In his free time, Omar enjoys trying new restaurants, playing basketball, and watching football (go Giants!).

      Melinda R. Cook, PharmD
      PGY-1 Training: Novant Health Presbyterian Medical Center, Charlotte, NC
      Education: University at Michigan College of Pharmacy, Ann Arbor, MI

      Dr. Cook was born and raised in St. Petersburg, FL. She received her Doctor of Pharmacy degree from the University at Michigan College of Pharmacy. She completed her PGY-1 Pharmacy Practice Residency at Novant Health Presbyterian Medical Center in Charlotte, NC. During her time as a PGY-1 resident, she was involved in research, including an evaluation of the safety and efficacy of the nivolumab 240 and 480 mg dosing schemes. She also received her teaching and learning certificate after lecturing and co-precepting pharmacy students. Her professional interests include hematologic malignancies, bone marrow transplant, cellular therapy, and ambulatory care. Upon completion of her PGY-2 Oncology Pharmacy Residency, she plans to practice as an oncology clinical specialist in the ambulatory care setting, with opportunities to precept and mentor pharmacy residents and students. In her spare time, Melinda enjoys playing ultimate frisbee, cross-stitching, and trying new restaurants and breweries.

      Pain Management/Palliative Care

      Joseph Ricciutti, PharmD
      PGY-1 Training: Mount Auburn Hospital, Cambridge, MA
      Education: MCPHS University, Boston, MA

      Joseph “Joey” Ricciutti grew up in West Greenwich, Rhode Island. He attended MCPHS University in Boston, Massachusetts, where he obtained his PharmD degree. Following graduation, Dr. Ricciutti completed his PGY-1 Residency training at Mount Auburn Hospital in Cambridge, Massachusetts. There, he conducted a research project evaluating the use of opioids in the emergency department. He also coupled his passion for teaching and pain management by developing a lecture and continuing education course on the topic of pain management in the setting of opioid use disorder. Joey's professional interests include pain management, palliative care, addiction, and academia.

      Medication-Use Safety and Policy

      Nhi Bui, PharmD
      PGY-1 Training: Cox Health Medical Center, Springfield, MO
      Education: The University of Kansas School of Pharmacy, Lawrence, KS

      Dr. Bui was born and raised in Vietnam until the age of 12, when she immigrated to the United States with her family. She completed both undergraduate and graduate school at the University of Kansas School of Pharmacy, with a Bachelor of Pharmaceutical Sciences and Doctorate of Pharmacy and a minor in Business. After pharmacy school, Dr. Bui completed a PGY-1 at CoxHealth Medical Center in Springfield, Missouri. During her time at CoxHealth, she completed her teaching certificate and a project on the adoption of a rituximab biosimilar into practice. With her interest in oncology and pharmacy administration, she decided to pursue a PGY-2 in Medication Safety and Policy at Dana-Farber. In addition to assisting with guideline development, she is involved in several safety research projects, including “Evaluation of Irinotecan’s Adverse Events at Two Different Infusion Rates,” and “The Effect of Infusion Rate Titration on Taxane-Related Hypersensitivity.” Her career goals are to become a medication safety officer or an oncology pharmacist and eventually step into an administrative role. Some of Nhi's hobbies are trying food from different cultures, weightlifting, painting, outdoor activities, spending time with her dog, and traveling.

      Past Residents

      2020-2021

      Oncology

      Shahrier Hossain, PharmD, BCOP
      PGY-1 Training: Albany Medical Center, Albany, NY
      Education: University at Buffalo: School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
      Current Position: Clinical Pharmacy Specialist, Myeloma; Dana-Farber Cancer Institute, Boston, MA

      Kristin Markiewicz, PharmD, BCOP
      PGY-1 Training: Novant Health Presbyterian Medical Center, Charlotte, NC
      Education: University at Buffalo: School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY
      Current Position: Clinical Pharmacy Specialist, Breast/Gyn; Hospital of the University of Pennsylvania – Abramson Cancer Center, Philadelphia, PA

      Pain Management/Palliative Care

      Molly Bacon, PharmD
      PGY-1 Training: UPMC Hamot, Erie, PA
      Education: South Carolina College of Pharmacy
      Current Position: Clinical Pharmacy Specialist- Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      Medication-Use Safety

      Angela Chen, PharmD
      PGY-1 Training: Bay Pines VA Healthcare System
      Education: Philadelphia College of Pharmacy
      Current Position: Regulatory Specialist; Dana-Farber Cancer Institute, Boston, MA

      2019-2020

      Oncology

      Eno-Abasi Inyang, PharmD, BCPS, BCOP
      PGY-1 Training: St. Joseph Medical Center, Tacoma, Washington
      Education: University of Southern California, Los Angeles, CA
      Current Position: Clinical Pharmacy Specialist, BMT; Dana-Farber Cancer Institute, Boston, MA

      Shawn Streeter, PharmD, BCOP
      PGY-1 Training: Riverside University Health System, Moreno Valley, California
      Education: University of North Carolina Eshleman School of Pharmacy, Chapel Hill, NC
      Current Position: Oncology Clinical Pharmacy Specialist, Myeloma/Lymphoma, City of Hope, Duarte, CA

      Pain Management/Palliative Care

      Annabelle Hood, PharmD
      PGY-1 Training: University of Charleston School of Pharmacy, Charleston, WV
      Education: MCPHS University, Boston, MA
      Current Position: Clinical Pharmacy Specialist, Pain Management, Cleveland Clinic

      Medication-Use Safety

      Grace Hwang, PharmD
      PGY-1 Training: Houston Methodist Hospital, Houston, Texas
      Education: University of Houston College of Pharmacy, Houston, TX
      Current Position: Clinical Pharmacist- Hematology/Oncology, Baylor St. Luke’s Medical Center

      2018-2019

      Oncology

      Megan Duperreault, PharmD, BCOP
      PGY-1 Training: Brigham and Women's Hospital, Boston, MA
      Education: South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, SC
      Current Position: Clinical Oncology Pharmacist – Hematology, Maine Medical Center, Portland, Maine

      Erin Grannan, PharmD, BCOP
      PGY-1 Training: MedStar Washington Hospital Center, Washington, DC
      Education: Philadelphia College of Pharmacy at the University of the Sciences, Philadelphia, PA
      Current Position: Clinical Pharmacy Specialist - Medical Breast Oncology, MD Anderson Cancer Center, Houston, TX

      Pain Management/Palliative Care

      Mara Hofherr, PharmD
      PGY-1 Training: Christian Hospital, St. Louis, MO
      Education: Saint Louis College of Pharmacy, St. Louis, MO
      Current Position: Oncology Clinical Pharmacist, Delbert Day Cancer Center, Rolla, Missouri

      Medication-Use Safety

      Garrett Rompelman, PharmD
      PGY-1 Training: Community Healthcare System - Community Hospital, Munster, IN
      Education: University of Illinois at Chicago College of Pharmacy, Chicago, IL
      Current Position: Clinical Infusion Pharmacist, Dana- Farber Cancer Institute, Boston, MA

      2017-2018

      Oncology

      Elaine Xiang, PharmD, BCOP     
      PGY-1 Training: NYU Langone Medical Center, New York, NY     
      Education: Northeastern University
      Current Position: Clinical Pharmacotherapy Specialist - Hematology/Oncology, New York University Langone Health, New York, NY

      Patrick McBride, PharmD, BCOP
      PGY-1 Training: Children's Hospital of Wisconsin, Milwaukee, WI     
      Education: MCPHS University, Boston, MA     
      Current Position: Oncology Clinical Pharmacist (Pediatrics), Dana-Farber Cancer Institute, Boston, MA

      Pain Management/Palliative Care

      Iman F. Suliman, PharmD
      PGY-1 Training: North Florida/South Georgia Veterans Health System    
      Education: University of Florida, Gainesville, FL     
      Current Position: Clinical Pharmacy Specialist-Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      2016-2017

      Oncology

      Huong (Heather) Truong, PharmD, BCOP     
      PGY-1: Yale New Haven Health system, New Haven, CT    
      Education: University of Connecticut School of Pharmacy
      Current Position: Hematology/Oncology Pharmacist, Mayo Clinic, Rochester, MN

      Mary Nauffal, PharmD, MS, BCOP     
      PGY-1: Brigham and Women's Hospital, Boston, MA     
      Education: Lebanese American University, Beirut, Lebanon     
      Current Position: Clinical Pharmacy Specialist, Bone Marrow Transplant, Memorial Sloan Kettering, New York, NY

      Pain Management/Palliative Care

      Benjamin S. Kematick, PharmD, BCACP
      PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
      Education: University at Buffalo, Buffalo, NY
      Current Position: Clinical Pharmacy Specialist - Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      2015-2016

      Oncology

      Jacob Barker, PharmD
      PGY-1: University of Michigan Health System, Ann Arbor, MI
      Education: University of New England School of Pharmacy, Portland, ME
      Current Position: Oncology Pharmacist Clinician, University of Vermont Medical Center, Burlington, VT

      Sydney Smith, PharmD, BCOP
      PGY-1: Cleveland Clinic, Cleveland, OH
      Education: Rosman University of Health Sciences, Henderson, NV
      Current Position: Stem Cell Transplant Clinical Pharmacist, Seattle Cancer Care Alliance, Seattle, WA

      2014-2015

      Oncology

      Doug Hackenyos, PharmD, BCOP     
      PGY-1: Tufts Medical Center, Boston, MA
      Education: MCPHS University, Worcester, MA
      Current Position: Oncology Pharmacy Clinical Coordinator, UConn Health, Farmington, CT

      Cynthia Herrera, PharmD, BCOP     
      PGY-1: Northwestern Memorial Hospital, Chicago, IL
      Education: Purdue University College of Pharmacy, West Lafayette, IN
      Current Position: Hematology/Oncology Clinical Pharmacist, Northwestern Medicine, Chicago, IL

      2013-2014

      Oncology

      Laura (Perry) Hackett, PharmD, BCOP     
      PGY-1: Dartmouth-Hitchcock Medical Center, Lebanon, NH
      Education: MCPHS University, Boston, MA
      Current Position: Hematology/Oncology Clinical Pharmacist, Dartmouth-Hitchcock Medical Center, Lebanon, NH

      Taylor Butler, PharmD, BCOP     
      PGY-1: Blount Memorial Hospital, Maryville, TN
      Education: University of Tennessee Health Science Center, Memphis and Knoxville, TN
      Current Position: Clinical Pharmacist, Tennessee Valley Veterans Affairs Health System, Nashville, TN

      2012-2013

      Oncology

      Amanda Dietzek, PharmD, BCOP
      PGY-1: Einstein Medical Center, Philadelphia, PA
      Education: Northeastern University, Boston, MA
      Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA

      Kelly Connelly, PharmD, BCOP     
      PGY-1: Mount Sinai Medical Center, New York, NY
      Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
      Current Position: Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD

      2011-2012

      Oncology

      Kelley Carlstrom, PharmD, BCOP
      PGY-1: Beth Israel Deaconess Medical Center, Boston, MA
      Education: University of Colorado, Denver College of Pharmacy, Denver, CO
      Current Position: Clinical Oncology Content Specialist, Project Ronin; CEO/Founder, KelleyCPharmD, LLC

      2010-2011

      Oncology

      Meredith W. H. Higley, PharmD, BCPS, BCOP
      PGY-1: Parkview Health, Fort Wayne, IN
      Education: MCPHS University, Boston, MA
      Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA

      2009-2010

      Oncology

      Houry Leblebjian, PharmD, BCOP
      PGY-1: UMass Memorial Medical Center, Worcester, MA
      Education: Lebanese American University, West Beirut, Lebanon
      Current Position: Clinical Pharmacy Manager, Dana-Farber Cancer Institute, Boston, MA

      2008-2009

      Oncology

      Jian Ni, PharmD, BCOP
      PGY-1: West Virginia University Hospital, Morgantown, WV
      Education: MCPHS University, Boston, MA
      Current Position: Hematology/Oncology Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA

      2007-2008

      Oncology

      Delila Katz, PharmD, BCOP
      PGY-1: Boston Medical Center, Boston, MA
      Current Position: Clinical Pharmacy Specialist, Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA

      2006-2007

      Oncology

      Victor Phantumvanit, PharmD, BCPS, BCOP
      PGY-1: Central Washington Hospital, Wenatchee, WA
      Education: University of Maryland, School of Pharmacy
      Current Position: Clinical Pharmacy Specialist, Palliative Care, Dana-Farber Cancer Institute, Boston, MA

      2005-2006

      Oncology

      Gayle Blouin, PharmD, BCOP
      Education: MCPHS University, Boston, MA
      Current Position: Clinical Pharmacy Manager-Satellites, Dana-Farber Cancer Institute, Boston, MA

    • Applying for the Pharmacy Residency

      Eligibility

      Interested applicants must have a PharmD degree and successfully complete an ASHP-accredited PGY-1 pharmacy residency prior to anticipated start date. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

      Application procedure

      Please submit your application through PhORCAS (Pharmacy Online Residency Centralized Application Service) — portal.phorcas.org — including:

      • Letter of intent
      • Curriculum vitae
      • Three letters of recommendation
      Application Deadlines

      Oncology: December 29, 2021
      Pain Management/Palliative Care and Medication-Use Safety: January 3, 2022
      Residency start date: First week in July


      Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups, as protected by law.